Skip to main content
Clinical Trials/NCT00542516
NCT00542516CompletedPhase 4

Comparison Between Two Techniques of Volemic Expansion in Hip Replacement Arthroplasty: Hydroxyethyl Starch Versus Ringer's Lactate

University of Sao Paulo1 site in 1 country48 target enrollmentStarted: September 2006Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
48
Locations
1
Primary Endpoint
HES expansion plasmatic efficacy

Study Overview

Brief Summary

Currently the most use solution to volemic reposition in hip replacement arthroplasty is the crystalloid solution. This trial intends to compare two different volemic replacements: HES and Ringer's lactate. This research has been analyzing hemodynamic parameters and the coagulation status before and after the pre-expansion with the solutions above mentioned.

Detailed Description

This trial is randomized an blind to the physician who is analyzing the results.It has been select adults; both sex; ASA I and II. These patients must be submitted to hip arthroplasty replacement. The anesthesia technique is single shot spinal anesthesia. Primary endpoint: assessment alternative; technique replacement volemic with HES 130/04. Secondary endpoint: haemostatic abnormalities; blood loss; transfusion blood.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Patients involved: adults, ASA I and II;
  • Surgery: hip replacement arthroplasty.

Exclusion Criteria

  • Allergy starch;
  • Dysfunction renal;
  • Heart insufficiency;
  • Morbid obesity.

Arms & Interventions

HES 130/04

Experimental

Pre-expansion with HES

Intervention: Hydroxyethyl Starch (Drug)

Ringer's lactate

Active Comparator

Pre-expansion with Ringer's lactate

Intervention: Hydroxyethyl Starch (Drug)

Ringer's lactate

Active Comparator

Pre-expansion with Ringer's lactate

Intervention: Ringer's lactate (Drug)

Outcomes

Primary Outcomes

HES expansion plasmatic efficacy

Time Frame: 24 hours

Secondary Outcomes

  • Blood transfusion(24 hours)
  • Haemostatic alterations(24 hours)

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials